Rosner Elimelech

CTO Rosner Elimelech sold 10,959 shares (11.0K) of HQY at $95.45 on 2025-12-18 for $1.0M, reducing stake 19.3%.

Rosner Elimelech, EVP and Chief Technology Officer, sold 10,959 shares at $95.45, a material 19.3% reduction in his HQY holdings. His prior two HQY sales (June 2025) showed negative 90-day returns of -10.2% and -9.2%, indicating well-timed exits, though his cross-ticker track record shows mixed timing with an average 90-day return of +1.4% across all open-market sells. HealthEquity trades at a P/E of 42.44 with strong fundamentals—$322.2M in quarterly revenue and +20.0% annual revenue growth—yet the stock is -16.6% from its 52-week high and -7.8% over the past 30 days. The substantial share reduction by a technology executive during a period of recent weakness warrants attention to whether near-term operational or market headwinds are driving the decision.

HQY CTO Rosner Elimelech sold 71,000 shares (71.0K) for $7,976,299.50 across 2 tranches; holdings cut 53.1%

Rosner Elimelech, EVP and Chief Technology Officer, executed 2 separate sales totaling 71,000 shares (71.0K shares) for $7,976,299.50 ($8.0M) at blended average price $112.34 on 2025-06-06 and 2025-06-09, reducing his holdings from 133,689 shares to 62,689 shares—a net reduction of 53.1% of pre-transaction holdings. The stock is now trading at $107.22, down 6.4% from the 52-week high of $114.51, and the CTO's sale prices of $112.56 and $111.37 sit near recent highs. Examining his same-ticker trade history, prior sells on 2024-09-06 and 2023-06-12 generated positive 90-day returns of 30.9% and 5.8% respectively—the stock rose after both sales, making neither well-timed from a sell perspective. This filing warrants close monitoring given the substantial reduction in the CTO's personal stake in the company he leads technologically, the proximity of sale prices to 52-week highs, and the company's elevated P/E of 76.04 relative to strong but decelerating fundamentals (20.0% annual revenue growth, $330.8M latest quarterly revenue, $53.9M net income).

CTO Rosner Elimelech sold 12,296 shares of HQY at $77.02 ($947.1K); post-sale holdings: 62,520 shares

Rosner Elimelech, EVP and Chief Technology Officer, executed an open-market sale of 12,296 shares on 2024-09-06 at $77.02 per share, reducing his stake by 16.4% to 62,520 shares post-transaction. At the transaction price of $77.02, the stock was trading near the midpoint of its 52-week range and 14.1% below its 52-week high of $86.94; the current price of $74.69 is 3.0% lower than the transaction price. Examining the insider's prior transaction at HQY (a sale on 2023-06-12), that trade saw a 90-day return of +5.8%, meaning the stock subsequently rose after the sale—not a well-timed signal. The insider's cross-ticker track record shows a 90-day well-timed rate of 0.00% across 1 prior open-market sell, indicating sell timing has not been a distinguishing feature of this executive's transaction history.